Literature DB >> 29900534

Absence of infiltrating peripheral myeloid cells in the brains of mouse models of lysosomal storage disorders.

Soo Min Cho1, Ayelet Vardi1, Nicolas Platt2, Anthony H Futerman1.   

Abstract

Approximately 70 lysosomal storage diseases are currently known, resulting from mutations in genes encoding lysosomal enzymes and membrane proteins. Defects in lysosomal enzymes that hydrolyze sphingolipids have been relatively well studied. Gaucher disease is caused by the loss of activity of glucocerebrosidase, leading to accumulation of glucosylceramide. Gaucher disease exhibits a number of subtypes, with types 2 and 3 showing significant neuropathology. Sandhoff disease results from the defective activity of β-hexosaminidase, leading to accumulation of ganglioside GM2. Niemann-Pick type C disease is primarily caused by the loss of activity of the lysosomal membrane protein, NPC1, leading to storage of cholesterol and sphingosine. All three disorders display significant neuropathology, accompanied by neuroinflammation. It is commonly assumed that neuroinflammation is the result of infiltration of monocyte-derived macrophages into the brain; for instance, cells resembling lipid-engorged macrophages ('Gaucher cells') have been observed in the brain of Gaucher disease patients. We now review the evidence that inflammatory macrophages are recruited into the brain in these diseases and then go on to provide some experimental data that, at least in the three mouse models tested, monocyte-derived macrophages do not appear to infiltrate the brain. Resident microglia, which are phenotypically distinct from infiltrating macrophages, are the only myeloid population present in significant numbers within the brain parenchyma in these authentic mouse models, even during the late symptomatic stages of disease when there is substantial neuroinflammation. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/. This article is part of the Special Issue "Lysosomal Storage Disorders".
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  Niemann-Pick Type C disease; gaucher disease; lysosomal storage disorders; microglia; monocyte-derived macrophages; sandhoff disease

Mesh:

Year:  2018        PMID: 29900534     DOI: 10.1111/jnc.14483

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

Review 1.  Gaucher disease: Basic and translational science needs for more complete therapy and management.

Authors:  Gregory A Grabowski; Armand H M Antommaria; Edwin H Kolodny; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-12-29       Impact factor: 4.797

2.  Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders.

Authors:  Enrique Gabandé-Rodríguez; Azucena Pérez-Cañamás; Beatriz Soto-Huelin; Daniel N Mitroi; Sara Sánchez-Redondo; Elena Martínez-Sáez; César Venero; Héctor Peinado; María Dolores Ledesma
Journal:  EMBO J       Date:  2018-12-07       Impact factor: 11.598

3.  Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy.

Authors:  Chandra Sekhar Boddupalli; Shiny Nair; Glenn Belinsky; Joseph Gans; Erin Teeple; Tri-Hung Nguyen; Sameet Mehta; Lilu Guo; Martin L Kramer; Jiapeng Ruan; Honggge Wang; Matthew Davison; Dinesh Kumar; D J Vidyadhara; Bailin Zhang; Katherine Klinger; Pramod K Mistry
Journal:  Elife       Date:  2022-08-16       Impact factor: 8.713

4.  Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis.

Authors:  Sharon Melamed; Roy Avraham; Deborah E Rothbard; Noam Erez; Tomer Israely; Ziv Klausner; Anthony H Futerman; Nir Paran; Einat B Vitner
Journal:  Acta Neuropathol Commun       Date:  2020-08-24       Impact factor: 7.801

5.  Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease.

Authors:  Ayelet Vardi; Shifra Ben-Dor; Soo Min Cho; Ulrich Kalinke; Julia Spanier; Anthony H Futerman
Journal:  J Neuroinflammation       Date:  2020-09-07       Impact factor: 8.322

6.  Single Cell Transcriptome Analysis of Niemann-Pick Disease, Type C1 Cerebella.

Authors:  Antony Cougnoux; Julia C Yerger; Mason Fellmeth; Jenny Serra-Vinardell; Kyle Martin; Fatemeh Navid; James Iben; Christopher A Wassif; Niamh X Cawley; Forbes D Porter
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.